EUVIMEDEUVIMED entdecken
Crossref

In-silico ADME, TOXICITY PREDICTION, MOLECULAR DOCKING STUDIES OF CHALCONE-MORPHOLINOTHIAZOLE DERIVATIVES AS POTENTIAL ESTROGEN RECEPTOR: Α ANTAGONISTS FOR BREAST CANCER THERAPY

M. R Rachala, T. C Maringanti

RASAYAN Journal of Chemistry · 2026 · 19 (02) · 939-946

DOI: 10.31788/rjc.2026.1929639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RASAYAN Journal of Chemistry, 2026. Verfasst von M. R Rachala und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains a major global health challenge, particularly hormone-dependent subtypes driven by estrogenreceptor alpha (ERα) signalling. Although endocrine therapies have improved clinical outcomes, resistance andadverse effects necessitate the development of alternative molecular scaffolds. In this study, a series of chalcone–morpholino thiazole derivatives (1a–1j) were evaluated using structure-based molecular docking against ERα(PDBID: 3ERT). Docking validation was performed using 4-hydroxytamoxifen as a reference. Compounds 1e, 1a, and1f exhibited the most favourable binding energies (−10.09 to −10.05 kcal/mol), approaching the reference ligand(−11.57 kcal/mol). Interaction analysis revealed stable hydrophobic accommodation with supportive π-interactionsand hydrogen bonding. ADMET prediction indicated good gastrointestinal absorption and acceptable drug-likenessfor most derivatives, although aqueous solubility may require optimisation. Frontier molecular orbital analysisdemonstrated suitable electronic characteristics supporting receptor interaction. These findings identify selectedderivatives as promising ERα-targeted candidates, warranting further biological validation, contributingtoSustainable Development Goal 3 (Good Health and Well-Being).

Zitieren

APA

Rachala, M. R., & Maringanti, T. C. (2026). In-silico ADME, TOXICITY PREDICTION, MOLECULAR DOCKING STUDIES OF CHALCONE-MORPHOLINOTHIAZOLE DERIVATIVES AS POTENTIAL ESTROGEN RECEPTOR: Α ANTAGONISTS FOR BREAST CANCER THERAPY. RASAYAN Journal of Chemistry, 19(02), 939-946. https://doi.org/10.31788/rjc.2026.1929639

Vancouver

Rachala MR, Maringanti TC. In-silico ADME, TOXICITY PREDICTION, MOLECULAR DOCKING STUDIES OF CHALCONE-MORPHOLINOTHIAZOLE DERIVATIVES AS POTENTIAL ESTROGEN RECEPTOR: Α ANTAGONISTS FOR BREAST CANCER THERAPY. RASAYAN Journal of Chemistry. 2026;19(02):939-946. doi:10.31788/rjc.2026.1929639

BibTeX
@article{Rachala2026,
  author = {Rachala, M. R and Maringanti, T. C},
  title = {In-silico ADME, TOXICITY PREDICTION, MOLECULAR DOCKING STUDIES OF CHALCONE-MORPHOLINOTHIAZOLE DERIVATIVES AS POTENTIAL ESTROGEN RECEPTOR: Α ANTAGONISTS FOR BREAST CANCER THERAPY},
  journal = {RASAYAN Journal of Chemistry},
  year = {2026},
  volume = {19},
  number = {02},
  pages = {939--946},
  doi = {10.31788/rjc.2026.1929639}
}
Kostenlos starten →